Skip to content
DraconiticResearch
Search Sources API
190,332 studies31 sourcesUpdated just now
PreprintAll rights reservedbioRxiv

An Injectable Antisense Oligonucleotide (ASO) Approach to Treat Obesity in Preclinical Models

  1. 1Baker Heart & Diabetes Institute

Related

  1. Gene-Specific Antisense Oligonucleotide Therapy Targeting AMA1: A Potential Malaria Treatment.
    Haleh Hanifian, Nader Shahrokhi, Mehdi Nateghpour +4
    Iranian journal of parasitologyPeer-reviewedCC BY-NCFull text1 citedEpidemiology & public healthEurope PMCPMC
  2. Population-scale genome-wide prioritization of targets for allele-specific antisense oligonucleotide therapy design
    R. Sakaki, L. W. Newton, B. Haque +7
    medRxivPreprintCC BY-NC-NDFull textHuman geneticsmedRxiv
  3. Mapping intronic mutational hotspots by in silico mutagenesis enables single antisense oligonucleotide correction of multiple variants
    H. Saei, B. Ardin, N. Kaiser +20
    medRxivPreprintCC BYFull textHuman geneticsmedRxiv
  4. Pre-Obesity and Preclinical Obesity: Disease-Specific Concepts or Generalisable Frameworks for Chronic Disease Classification?
    Matteo Monami, Francesco Giorgino, Claudio Borghi +3
    Diabetes/metabolism research and reviewsPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMC
  5. From cryptic exons to neuronal dysfunction: combinatorial antisense makes sense in TAR DNA-binding protein-43 (TDP-43) pathology.
    Gianluca Figlia, Juliane Bremer
    Signal transduction and targeted therapyPeer-reviewedCC BY-NC-NDFull textNeurologyEurope PMCDOAJ
BibTeX
@misc{drew2026injectable,
  title = {{An Injectable Antisense Oligonucleotide (ASO) Approach to Treat Obesity in Preclinical Models}},
  author = {B. G. Drew and S. T. Bond and M. F. Keating and Y. Liu and C. Yang and K. Liu and A. C. Parslow and M. Inouye and A. C. Calkin},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.12.753973},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.12.753973v1},
}
RIS
TY  - UNPB
TI  - An Injectable Antisense Oligonucleotide (ASO) Approach to Treat Obesity in Preclinical Models
AU  - B. G. Drew
AU  - S. T. Bond
AU  - M. F. Keating
AU  - Y. Liu
AU  - C. Yang
AU  - K. Liu
AU  - A. C. Parslow
AU  - M. Inouye
AU  - A. C. Calkin
PY  - 2026
DA  - 2026/10/12
PB  - bioRxiv
DO  - 10.64898/2026.10.12.753973
UR  - https://www.biorxiv.org/content/10.64898/2026.10.12.753973v1
ER  -